The c-Myc expression is required for the estrogen-independent proliferation of breast cancer cells expressing ERαY537S and ERαD538G mutations and the c-Myc alone is sufficient to confer antiestrogen resistance in human breast cancer (95). Here, MYC is linked to breast carcinoma.